2 recession-proof stocks for 2017

Could these shares be the perfect antidote to any Brexit-related anxiety?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As we creep towards 2017 and our eventual exit from the EU, it’s likely that more investors will look towards companies that offer services or products that we’ll buy whatever the weather (or economic climate). Utilities and consumer staples will inevitably garner the most attention and, if history is anything to go by, justifiably so. Nevertheless, there’s one niche market out there that I think offers a perfect blend of defensive qualities and dynamic growth, namely that which focuses on the UK’s love of pets. Let’s look at two examples of companies operating in this area, one of which reported to the market earlier today.

Resilient market

Despite the substantial drop in its share price this morning (down almost 8%), £1.15bn retailer Pets At Home‘s (LSE: PETS) interim figures aren’t bad at all. Over the last six months, like-for-like revenue across the group was up by 2.5% with food sales rising by 3.7% and accessories by 5.9%. Even more positive was the 47.6% growth in its veterinary business from £41.9m to £61.9m. 

Elsewhere, the Wilmslow-based company reported that investment in its online offering was “delivering results” and that its space rollout remains on track with eight new superstores, 17 vet practices and 18 grooming salons opening over the past year. For those who like to focus on fundamentals, Pets At Home also reported an 11.5% rise in free cashflow to £34.4m and a reduction in leverage from 1.5 times to 1.3 times. This last detail is noteworthy as it shows that the company is continuing to focus on steadily reducing its debt pile, no bad thing in an uncertain economic climate. While reflecting that the trading environment wasn’t easy, CEO Ian Kellett remarked that the company was “confident in the long-term outlook” and the “developing potential” of the aforementioned Services business.

On a forecast price-to-earnings (P/E) ratio of 15, I’d say that shares in Pets in Home are reasonably valued and, thanks to today’s 25% dividend hike, should now feature prominently on the radars of those who invest for income.

Small-cap star 

For those who prefer smaller companies, an alternative to Pets At Home might be CVS Group (LSE: CVSG). The £539m cap is the largest veterinary group in the UK and, with good reason, has attracted quite a following among those who hunt for shares at the lower end of the market spectrum. Over the last five years, its share price has rocketed 1,000% thanks to consistent growth in revenue and net profits. Only today, it’s up 12.5%.

Can this fantastic run of form continue? Quite possibly. A rise of almost 170% in earnings per share has been pencilled-in for 2017. Moreover, the company’s recent acquisition of a small animal practice based in the east of the Netherlands is intended to be the first step in the development of a similar business to that operating in the UK. One thing’s for sure, CVS isn’t standing still.

Any downsides? Well, on a forecast price-to-earnings (P/E) ratio of 24 for 2017, shares in a CVS are rather expensive and unlikely to be of interest to those who scour the market for value. Nevertheless, those with stronger appetites for risk and longer investing horizons may be tempted and given the company’s strong pipeline of acquisitions, I wouldn’t blame them.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

5 investment trusts to consider for a new 2025 ISA

The biggest challenge when starting an ISA is choosing which stocks to buy. Investment trusts can make it a whole…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

Have I left it too late to buy Nvidia shares?

When the whole world was racing to buy Nvidia shares, Harvey Jones decided they were overhyped. Does the recent dip…

Read more »

Dividend Shares

I asked ChatGPT to pick me the best passive income stock. Here’s the result!

Jon Smith tries to make friends with ChatGPT and critiques the best passive income pick the AI tool suggested for…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Hargreaves Lansdown’s clients are buying loads of this US growth stock. Should I?

Our writer's noticed that during the week after Christmas, many investors bought this US growth stock. He asks whether he…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Greggs shares plunge 11% despite growing sales. Is this my chance to buy?

As the company’s Q4 trading update reveals 8% revenue growth, Greggs shares are falling sharply. Should Stephen Wright be rushing…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

Will ‘biggest ever Christmas’ help keep the Tesco share price climbing in 2025?

The Tesco share price had a great year in 2024. And if 2025 trading continues in the same way, we…

Read more »

Investing Articles

This dirt cheap UK income stock yields 8.7% and is forecast to rise 45% this year!

After a disappointing year Harvey Jones thinks this FTSE 100 income stock is now one worth considering for investors seeking…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

With much to be cheerful about, why is this FTSE 250 boss unhappy?

JD Wetherspoon, the FTSE 250 pub chain, is a British success story. But the government’s budget has failed to lift…

Read more »